Clinical Research on a Novel Deep-learning Based System in Mediastinal Endoscopic Ultrasound Scanning
- Conditions
- Mediastinum Disease
- Registration Number
- NCT05792280
- Brief Summary
The goal of this clinical trial is to develop and verify the auxiliary role of the artificial intelligence system in mediastinal ultrasound endoscopic scanning. The main questions it aims to answer are as follows: 1.The comparison of the image recognition accuracy between the artificial intelligence system and the ultrasound endoscopist; 2. Whether the artificial intelligence system can improve the integrity and efficiency of the mediastinum scanning for the ultrasound endoscopist. Participants will undergo mediastinal EUS with or without the assistance of the artificial intelligence system.
- Detailed Description
In this study, a total of 200 cases of mediastinal endoscopic ultrasound scanning videos will be collected. First of all, an artificial intelligence system based on deep learning for the navigation and quality control of mediastinal endoscopic ultrasonography will be established. Secondly, the artificial intelligence system will be used to identify the site and anatomical structure of the mediastinal ultrasound endoscope, and the results of the artificial intelligence system's station recognition will be compared with the results of the endoscopist's station recognition. Finally, the completeness of standard sites and scanning time of endoscopic-assisted and non-assisted AI systems were compared.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 180
-
- Age ≥18 years old, <80 years old 2.Patients who need endoscopic ultrasonography; 3. Agree to participate in this study and sign the informed consent form.
- Subjects who meet any of the following criteria cannot be selected for this trial:
First. The patient's physical condition does not meet the requirements of conventional endoscopic ultrasonography:
- Poor physical condition, including hemoglobin ≤8.0g/dl, severe cardiopulmonary insufficiency, etc.
- Anesthesia assessment failed
- Pregnancy or breastfeeding
- In the acute stage of chemical and corrosive injury, it is very easy to cause perforation
- Recent acute coronary syndrome or clinically unstable ischemic heart attack
- Heart disease patients with right-to-left shunt, patients with severe pulmonary hypertension (pulmonary artery pressure> 90mmHg),patients with uncontrolled systemic hypertension and patients with adult respiratory distress syndrome.
Second. Disagree to participate in this study.
Third. There are other problems that do not meet the requirements of this research or that affect the results of the research:
- Mediastinal lesions have previously undergone surgery or radiotherapy and chemotherapy;
- Mental illness, drug addiction, inability to express themselves or other diseases that may affect follow-up.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method The completeness for standard station scanning Until the end of the study This was calculated as the number of stations successfully scanned divided by the total number of stations that should have been scanned.
Accuracy 1 year The number of correctly classified images divided by the total number of images.
- Secondary Outcome Measures
Name Time Method The incidence of adverse events Until the end of the study The incidence of adverse events in both groups during the entire research process.
The completeness for standard stations and anatomical landmarks per individual Until the end of the study The completeness of stations and anatomic landmarks of endoscopic ultrasonography by different endoscopists in the AI system assisted group and the control group were compared.
The completeness of anatomical landmarks Until the end of the study It calculated as the number of anatomical structures successfully scanned divided by the total number of structures that should have been scanned
Operation time Until the end of the study In addition to puncture, elastography, and ultrasound enhancement to observe the lesion or treatment, it can also be used to observe the time of the mediastinum.
Cohen's kappa coefficient 1 year This data is to evaluate the agreement between the model and the endoscopists.
Trial Locations
- Locations (1)
The Third Xiangya Hospital of Central South University
🇨🇳Changsha, Hunan, China
The Third Xiangya Hospital of Central South University🇨🇳Changsha, Hunan, ChinaXiaoyan Wang, DoctorContact+8613974889301wxy20011@163.comShiqin Huang, DoctorContact+8618308312098sqhuang0213@163.com